Centrifugal enhancement of Kaposi's sarcoma-associated virus infection of human endothelial cells in vitro
- 1 December 2008
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 154 (1-2) , 160-166
- https://doi.org/10.1016/j.jviromet.2008.07.026
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial CellsJournal of Virology, 2003
- Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Infection of Human Fibroblast Cells Occurs through EndocytosisJournal of Virology, 2003
- Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and PathogenesisMicrobiology and Molecular Biology Reviews, 2003
- Cell Surface Heparan Sulfate Is a Receptor for Human Herpesvirus 8 and Interacts with Envelope Glycoprotein K8.1Journal of Virology, 2001
- Human Herpesvirus 8 Envelope-Associated Glycoprotein B Interacts with Heparan Sulfate-like MoietiesVirology, 2001
- Human Herpesvirus 8 Interaction with Target Cells Involves Heparan SulfateVirology, 2001
- Kaposi's Sarcoma-Associated Herpesvirus Can Productively Infect Primary Human Keratinocytes and Alter Their Growth PropertiesJournal of Virology, 2001
- KSHV and Kaposi's Sarcoma: The End of the Beginning?Cell, 1997
- Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitroJournal of Leukocyte Biology, 1993
- Further studies on the mechanism of centrifugal enhancement of cytomegalovirus infectivityJournal of Virological Methods, 1988